Publication | Closed Access
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma
43
Citations
18
References
2021
Year
Hematological MalignancyVersus Conventional TreatmentMedicineImmunologyHematologyImmunotherapyOncologyRelapsed/refractory Multiple MyelomaMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1